Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • P2Y Receptor
    (1)
  • Thrombin
    (1)
  • Others
    (2)
Filter
Search Result
Results for "

acute coronary syndromes

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
Enoxaparin sodium
T22323679809-58-6
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI)
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Lefradafiban
BIBU 104, BIBU104, BIBU-104
T27808149503-79-7In house
Lefradafiban(BIBU-104) is an oral platelet glycoprotein IIb IIIa receptor antagonist for the study of angina pectoris and acute coronary syndromes.
  • $205
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Iodofiltic acid
T68088116754-87-1In house
Iodofiltic acid can be used in the adjuvant treatment of acute coronary syndromes (Zeus ACS) and can be imaged to detect myocardial ischemia.
  • $80
In Stock
Size
QTY
Ticagrelor metabolite M5
Ticagrelor metabolite M5,, T437700, AR-C133913XX
T210591251765-07-7
Ticagrelor metabolite M5 (T437700) is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has faster and more consistent inhibition on ADP-receptors. Ticagrelor is used in the treatment of acute coronary syndromes (ACS).
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Sale